Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	epidermal growth factor receptor activity	ERBB4 EGFR	9.94e-05	4	82	2	GO:0005006
GeneOntologyMolecularFunction	transmembrane receptor protein tyrosine kinase activity	ERBB2 ERBB4 CRIM1 EGFR	1.48e-04	65	82	4	GO:0004714
GeneOntologyMolecularFunction	neuregulin binding	ERBB4 ITGA6	2.47e-04	6	82	2	GO:0038132
GeneOntologyMolecularFunction	transmembrane receptor protein kinase activity	ERBB2 ERBB4 CRIM1 EGFR	4.15e-04	85	82	4	GO:0019199
GeneOntologyMolecularFunction	growth factor binding	ERBB2 ERBB4 EGFR ITGA6 LTBP2	4.59e-04	156	82	5	GO:0019838
GeneOntologyCellularComponent	basal part of cell	SLC6A13 ERBB2 ERBB4 SLC2A9 EGFR PKD1 ITGA6 MARK2 ABCC6 CASK	1.99e-06	378	81	10	GO:0045178
GeneOntologyCellularComponent	basolateral plasma membrane	SLC6A13 ERBB2 ERBB4 SLC2A9 EGFR PKD1 ITGA6 ABCC6 CASK	4.09e-06	320	81	9	GO:0016323
GeneOntologyCellularComponent	basal plasma membrane	SLC6A13 ERBB2 ERBB4 SLC2A9 EGFR PKD1 ITGA6 ABCC6 CASK	9.24e-06	354	81	9	GO:0009925
GeneOntologyCellularComponent	cell projection membrane	ERBB2 SLC9A5 EGFR PACSIN1 PKD1 CDHR5 CNGA2 CASK	2.64e-04	431	81	8	GO:0031253
GeneOntologyCellularComponent	neuromuscular junction	ERBB2 ERBB4 LAMA2 CAV3	9.46e-04	112	81	4	GO:0031594
GeneOntologyCellularComponent	Golgi-associated vesicle	PACSIN1 PKD1 BACE1 CNGA2	1.01e-03	114	81	4	GO:0005798
Domain	Tyr_kinase_EGF/ERB/XmrK_rcpt	ERBB2 ERBB4 EGFR	3.13e-07	4	81	3	IPR016245
Domain	GF_recep_IV	ERBB2 ERBB4 EGFR	1.56e-06	6	81	3	PF14843
Domain	GF_recep_IV	ERBB2 ERBB4 EGFR	1.56e-06	6	81	3	IPR032778
Domain	Furin-like	ERBB2 ERBB4 EGFR	2.72e-06	7	81	3	PF00757
Domain	Rcpt_L-dom	ERBB2 ERBB4 EGFR	2.72e-06	7	81	3	IPR000494
Domain	Furin-like_Cys-rich_dom	ERBB2 ERBB4 EGFR	2.72e-06	7	81	3	IPR006211
Domain	Recep_L_domain	ERBB2 ERBB4 EGFR	2.72e-06	7	81	3	PF01030
Domain	-	ERBB2 ERBB4 EGFR	2.72e-06	7	81	3	3.80.20.20
Domain	TECPR	HERC2 TECPR1	5.56e-05	3	81	2	SM00706
Domain	Beta-propeller_rpt_TECPR	HERC2 TECPR1	5.56e-05	3	81	2	IPR006624
Domain	Growth_fac_rcpt_	CD93 ERBB2 ERBB4 CRIM1 EGFR LTBP2	5.97e-05	156	81	6	IPR009030
Domain	Furin_repeat	ERBB2 ERBB4 EGFR	6.12e-05	18	81	3	IPR006212
Domain	FU	ERBB2 ERBB4 EGFR	6.12e-05	18	81	3	SM00261
Domain	-	RCC1L HERC2 TECPR1	1.14e-04	22	81	3	2.130.10.30
Domain	RCC1/BLIP-II	RCC1L HERC2 TECPR1	1.31e-04	23	81	3	IPR009091
Domain	Mit_uncoupling	SLC25A14 SLC25A30	1.19e-03	12	81	2	IPR002030
Domain	CRYSTALLIN_BETA_GAMMA	CRYGS CRYBG1	1.88e-03	15	81	2	PS50915
Domain	Crystall	CRYGS CRYBG1	1.88e-03	15	81	2	PF00030
Domain	Beta/gamma_crystallin	CRYGS CRYBG1	1.88e-03	15	81	2	IPR001064
Domain	XTALbg	CRYGS CRYBG1	1.88e-03	15	81	2	SM00247
Domain	G_crystallin-rel	CRYGS CRYBG1	2.72e-03	18	81	2	IPR011024
Domain	ZZ	TADA2B HERC2	2.72e-03	18	81	2	PF00569
Domain	NA_NEUROTRAN_SYMP_2	SLC6A13 SLC6A16	2.72e-03	18	81	2	PS00754
Domain	ZF_ZZ_2	TADA2B HERC2	2.72e-03	18	81	2	PS50135
Domain	ZF_ZZ_1	TADA2B HERC2	2.72e-03	18	81	2	PS01357
Domain	L_dom-like	ERBB2 ERBB4 CMIP EGFR PKD1 LMOD2	3.01e-03	328	81	6	IPR032675
Domain	Znf_ZZ	TADA2B HERC2	3.03e-03	19	81	2	IPR000433
Domain	SNF	SLC6A13 SLC6A16	3.03e-03	19	81	2	PF00209
Domain	NA_NEUROTRAN_SYMP_1	SLC6A13 SLC6A16	3.03e-03	19	81	2	PS00610
Domain	NA_NEUROTRAN_SYMP_3	SLC6A13 SLC6A16	3.03e-03	19	81	2	PS50267
Domain	ZnF_ZZ	TADA2B HERC2	3.03e-03	19	81	2	SM00291
Domain	Na/ntran_symport	SLC6A13 SLC6A16	3.03e-03	19	81	2	IPR000175
Domain	RCC1	RCC1L HERC2	3.36e-03	20	81	2	PF00415
Domain	RCC1_1	RCC1L HERC2	3.70e-03	21	81	2	PS00625
Domain	RCC1_2	RCC1L HERC2	3.70e-03	21	81	2	PS00626
Domain	RCC1_3	RCC1L HERC2	3.70e-03	21	81	2	PS50012
Domain	-	GLB1L LAMA2 HERC2	3.93e-03	73	81	3	2.60.120.260
Domain	Reg_chr_condens	RCC1L HERC2	4.06e-03	22	81	2	IPR000408
Domain	fn3	ROBO4 CNTN5 IGSF9 CDON	5.41e-03	162	81	4	PF00041
Pathway	REACTOME_ERBB2_ACTIVATES_PTK6_SIGNALING	ERBB2 ERBB4 EGFR	8.58e-06	11	54	3	MM15478
Pathway	REACTOME_ERBB2_ACTIVATES_PTK6_SIGNALING	ERBB2 ERBB4 EGFR	1.48e-05	13	54	3	M27729
Pathway	REACTOME_ERBB2_REGULATES_CELL_MOTILITY	ERBB2 ERBB4 EGFR	1.48e-05	13	54	3	MM15320
Pathway	REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING	ERBB2 ERBB4 EGFR	1.88e-05	14	54	3	MM14761
Pathway	REACTOME_SHC1_EVENTS_IN_ERBB2_SIGNALING	ERBB2 ERBB4 EGFR	1.88e-05	14	54	3	MM14531
Pathway	PID_ERBB_NETWORK_PATHWAY	ERBB2 ERBB4 EGFR	2.34e-05	15	54	3	M201
Pathway	REACTOME_ERBB2_REGULATES_CELL_MOTILITY	ERBB2 ERBB4 EGFR	2.34e-05	15	54	3	M27608
Pathway	PID_A6B1_A6B4_INTEGRIN_PATHWAY	ERBB2 EGFR LAMA2 ITGA6	2.78e-05	46	54	4	M239
Pathway	REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING	ERBB2 ERBB4 EGFR	2.87e-05	16	54	3	M562
Pathway	REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING	ERBB2 ERBB4 EGFR	2.87e-05	16	54	3	M570
Pathway	REACTOME_SHC1_EVENTS_IN_ERBB2_SIGNALING	ERBB2 ERBB4 EGFR	7.77e-05	22	54	3	M26929
Pathway	BIOCARTA_HER2_PATHWAY	ERBB2 ERBB4 EGFR	8.91e-05	23	54	3	MM1480
Pathway	BIOCARTA_HER2_PATHWAY	ERBB2 ERBB4 EGFR	8.91e-05	23	54	3	M18719
Pathway	WP_FOCAL_ADHESION	ERBB2 EGFR LAMA2 ITGA6 PRKCG CAV3	1.08e-04	199	54	6	M39402
Pathway	KEGG_FOCAL_ADHESION	ERBB2 EGFR LAMA2 ITGA6 PRKCG CAV3	1.08e-04	199	54	6	M7253
Pathway	KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_UBIQUITINATION_OF_RTK_BY_CBL	ERBB2 ERBB4 EGFR	1.15e-04	25	54	3	M47934
Pathway	WP_ALPHA_6_BETA_4_INTEGRIN_SIGNALING_PATHWAY	ERBB2 EGFR LAMA2 ITGA6	1.16e-04	66	54	4	MM15925
Pathway	REACTOME_SIGNALING_BY_ERBB2_IN_CANCER	ERBB2 ERBB4 EGFR	1.30e-04	26	54	3	M29535
Pathway	REACTOME_DOWNREGULATION_OF_ERBB2_SIGNALING	ERBB2 ERBB4 EGFR	1.30e-04	26	54	3	MM15501
Pathway	REACTOME_DOWNREGULATION_OF_ERBB2_SIGNALING	ERBB2 ERBB4 EGFR	1.81e-04	29	54	3	M27756
Pathway	WP_MAMMARY_GLAND_DEVELOPMENT_PREGNANCY_AND_LACTATION_STAGE_3_OF_4	ERBB2 ERBB4 EGFR	2.67e-04	33	54	3	M39455
Pathway	KEGG_MEDICUS_VARIANT_ERBB2_OVEREXPRESSION_TO_EGF_JAK_STAT_SIGNALING_PATHWAY	ERBB2 EGFR	2.99e-04	7	54	2	M47431
Pathway	KEGG_ERBB_SIGNALING_PATHWAY	ERBB2 ERBB4 EGFR PRKCG	3.38e-04	87	54	4	M12467
Pathway	BIOCARTA_KREB_PATHWAY	ACO2 IDH2	3.97e-04	8	54	2	M6831
Pathway	KEGG_MEDICUS_REFERENCE_TGFA_EGFR_PLCG_PKC_SIGNALING_PATHWAY	EGFR PRKCG	3.97e-04	8	54	2	M47479
Pathway	WP_ERBB_SIGNALING	ERBB2 ERBB4 EGFR PRKCG	4.19e-04	92	54	4	M39715
Pathway	KEGG_MEDICUS_REFERENCE_CITRATE_CYCLE_FIRST_CARBON_OXIDATION	ACO2 IDH2	5.10e-04	9	54	2	M47937
Pathway	REACTOME_SIGNALING_BY_ERBB2	ERBB2 ERBB4 EGFR	6.30e-04	44	54	3	MM14520
Pathway	WP_ERBB_SIGNALING_PATHWAY	ERBB2 ERBB4 EGFR	7.18e-04	46	54	3	MM15950
Pathway	WP_FOCAL_ADHESION	ERBB2 EGFR LAMA2 ITGA6 CAV3	7.27e-04	187	54	5	MM15913
Pathway	PID_INTEGRIN4_PATHWAY	LAMA2 ITGA6	7.75e-04	11	54	2	M158
Pathway	REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING	ERBB2 ERBB4	7.75e-04	11	54	2	MM14760
Pathway	REACTOME_SIGNALING_BY_PTK6	ERBB2 ERBB4 EGFR	8.14e-04	48	54	3	MM15479
Pathway	REACTOME_SIGNALING_BY_ERBB2	ERBB2 ERBB4 EGFR	9.17e-04	50	54	3	M553
Pathway	KEGG_MEDICUS_VARIANT_ERBB2_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY	ERBB2 EGFR	9.27e-04	12	54	2	M47393
Pathway	REACTOME_SIGNALING_BY_PTK6	ERBB2 ERBB4 EGFR	1.15e-03	54	54	3	M29742
Pathway	KEGG_NON_SMALL_CELL_LUNG_CANCER	ERBB2 EGFR PRKCG	1.15e-03	54	54	3	M19818
Pathway	KEGG_MEDICUS_REFERENCE_RTK_PLCG_ITPR_SIGNALING_PATHWAY	ERBB2 ERBB4 EGFR	1.21e-03	55	54	3	M47952
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_PLCG_ERK_SIGNALING_PATHWAY	EGFR PRKCG	1.27e-03	14	54	2	M47383
Pathway	REACTOME_TFAP2_AP_2_FAMILY_REGULATES_TRANSCRIPTION_OF_GROWTH_FACTORS_AND_THEIR_RECEPTORS	ERBB2 EGFR	1.46e-03	15	54	2	M27766
Pathway	KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_ERK_SIGNALING_PATHWAY	EGFR PRKCG	1.46e-03	15	54	2	M47382
Pathway	REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS	LAMA2 ITGA6 CASK	1.48e-03	59	54	3	M27218
Pathway	KEGG_MEDICUS_REFERENCE_EGF_ERBB2_RAS_ERK_SIGNALING_PATHWAY	ERBB2 EGFR	1.67e-03	16	54	2	M47381
Pathway	REACTOME_SIGNALING_BY_ERBB2_ECD_MUTANTS	ERBB2 EGFR	1.67e-03	16	54	2	M29847
Pathway	PID_SYNDECAN_3_PATHWAY	EGFR CASK	1.89e-03	17	54	2	M251
Pathway	WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS	ERBB2 ERBB4 EGFR	2.05e-03	66	54	3	M39642
Pathway	WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STRESS_PATHWAY	PKD1 LOXL4	2.12e-03	18	54	2	M39586
Pathway	WP_MAMMARY_GLAND_DEVELOPMENT_EMBRYONIC_DEVELOPMENT_STAGE_1_OF_4	ERBB4 ITGA6	2.12e-03	18	54	2	M39327
Pathway	REACTOME_MATURATION_OF_TCA_ENZYMES_AND_REGULATION_OF_TCA_CYCLE	ACO2 IDH2	2.12e-03	18	54	2	MM17239
Pathway	WP_TCA_CYCLE_AKA_KREBS_OR_CITRIC_ACID_CYCLE	ACO2 IDH2	2.12e-03	18	54	2	M39460
Pathway	REACTOME_MATURATION_OF_TCA_ENZYMES_AND_REGULATION_OF_TCA_CYCLE	ACO2 IDH2	2.62e-03	20	54	2	M48266
Pathway	REACTOME_VXPX_CARGO_TARGETING_TO_CILIUM	PKD1 CNGA2	2.62e-03	20	54	2	MM15208
Pathway	WP_NONSMALL_CELL_LUNG_CANCER	ERBB2 EGFR PRKCG	2.63e-03	72	54	3	M39738
Pathway	REACTOME_VXPX_CARGO_TARGETING_TO_CILIUM	PKD1 CNGA2	2.89e-03	21	54	2	M27479
Pubmed	Spontaneous activation and signaling by overexpressed epidermal growth factor receptors in glioblastoma cells.	ERBB2 ERBB4 EGFR	1.26e-08	3	82	3	12532415
Pubmed	Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype.	ERBB2 EGFR ITGA6	1.26e-08	3	82	3	7618084
Pubmed	ErbB receptors protect the perfused heart against injury induced by epinephrine combined with low-flow ischemia.	ERBB2 ERBB4 EGFR	1.26e-08	3	82	3	19370475
Pubmed	Absence of EGFR, ERBB2 and ERBB4 mutation homologous to the oncogenic ERBB3 Val-104 mutation in colorectal cancers.	ERBB2 ERBB4 EGFR	1.26e-08	3	82	3	24862237
Pubmed	Cell surface expression of epidermal growth factor receptor and Her-2 with nuclear expression of Her-4 in primary osteosarcoma.	ERBB2 ERBB4 EGFR	1.26e-08	3	82	3	15026342
Pubmed	Association of ErbB1-4 expression in invasive breast cancer with clinicopathological characteristics and prognosis.	ERBB2 ERBB4 EGFR	1.26e-08	3	82	3	23100016
Pubmed	Kinase activator-receiver preference in ErbB heterodimers is determined by intracellular regions and is not coupled to extracellular asymmetry.	ERBB2 ERBB4 EGFR	1.26e-08	3	82	3	25468910
Pubmed	The relation between survival and expression of HER1 and HER2 depends on the expression of HER3 and HER4: a study in bladder cancer patients.	ERBB2 ERBB4 EGFR	5.04e-08	4	82	3	16685269
Pubmed	Characterisation of HER heterodimers in breast cancer using in situ proximity ligation assay.	ERBB2 ERBB4 EGFR	5.04e-08	4	82	3	24557338
Pubmed	Inverse regulation of EGFR/HER1 and HER2-4 in normal and malignant human breast tissue.	ERBB2 ERBB4 EGFR	5.04e-08	4	82	3	23991224
Pubmed	Expression of epidermal growth factors, erbBs, in the nasal mucosa of patients with chronic hypertrophic rhinitis.	ERBB2 ERBB4 EGFR	5.04e-08	4	82	3	22327010
Pubmed	Epidermal growth factor receptor activation in glioblastoma through novel missense mutations in the extracellular domain.	ERBB2 ERBB4 EGFR	5.04e-08	4	82	3	17177598
Pubmed	The relevance of EGFR, ErbB receptors and neuregulins in human adipocytes and adipose tissue in obesity.	ERBB2 ERBB4 EGFR	5.04e-08	4	82	3	36411648
Pubmed	HER2 phosphorylation is maintained by a PKB negative feedback loop in response to anti-HER2 herceptin in breast cancer.	ERBB2 ERBB4 EGFR	5.04e-08	4	82	3	21203579
Pubmed	ErbB2 and ErbB4 Cbl binding sites can functionally replace the ErbB1 Cbl binding site.	ERBB2 ERBB4 EGFR	5.04e-08	4	82	3	19263517
Pubmed	The leucine-rich repeat protein LRIG1 is a negative regulator of ErbB family receptor tyrosine kinases.	ERBB2 ERBB4 EGFR	5.04e-08	4	82	3	15345710
Pubmed	Analysis of ErbB receptors in pulmonary carcinoid tumors.	ERBB2 ERBB4 EGFR	5.04e-08	4	82	3	19447869
Pubmed	Evaluation of the prognostic and predictive value of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) study.	ERBB2 ERBB4 EGFR	5.04e-08	4	82	3	18985033
Pubmed	Heparin-binding EGF-like growth factor and ErbB signaling is essential for heart function.	ERBB2 ERBB4 EGFR	5.04e-08	4	82	3	12621152
Pubmed	Activation of ErbB4 by the bifunctional epidermal growth factor family hormone epiregulin is regulated by ErbB2.	ERBB2 ERBB4 EGFR	5.04e-08	4	82	3	9556621
Pubmed	Activated HER-receptors in predicting outcome of ER-positive breast cancer patients treated with adjuvant endocrine therapy.	ERBB2 ERBB4 EGFR	5.04e-08	4	82	3	22854050
Pubmed	The erbB/HER type 1 tyrosine kinase receptor family.	ERBB2 ERBB4 EGFR	5.04e-08	4	82	3	9771475
Pubmed	Expression of the HER-1-4 family of receptor tyrosine kinases in neuroendocrine tumours.	ERBB2 ERBB4 EGFR	5.04e-08	4	82	3	20204273
Pubmed	Laminin-1 and epidermal growth factor family members co-stimulate fetal pancreas cell proliferation and colony formation.	ERBB2 ERBB4 EGFR	5.04e-08	4	82	3	15733067
Pubmed	WW domain-containing protein YAP associates with ErbB-4 and acts as a co-transcriptional activator for the carboxyl-terminal fragment of ErbB-4 that translocates to the nucleus.	ERBB2 ERBB4 EGFR	5.04e-08	4	82	3	12807903
Pubmed	HER Family Protein Expression in a Greek Population with Gastric Cancer. A Retrospective Hellenic Cooperative Oncology Group Study.	ERBB2 ERBB4 EGFR	5.04e-08	4	82	3	27069134
Pubmed	A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor.	ERBB2 ERBB4 EGFR	5.04e-08	4	82	3	8816440
Pubmed	Evaluation of the prognostic significance of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) validation study.	ERBB2 ERBB4 EGFR	5.04e-08	4	82	3	26021752
Pubmed	Tissue interaction mediated by neuregulin-1 and ErbB receptors regulates epithelial morphogenesis of mouse embryonic submandibular gland.	ERBB2 ERBB4 EGFR	1.26e-07	5	82	3	15254894
Pubmed	Dominance of ErbB-1 heterodimers in lung epithelial cells overexpressing ErbB-2. Both ErbB-1 and ErbB-2 contribute significantly to tumorigenicity.	ERBB2 ERBB4 EGFR	1.26e-07	5	82	3	10572067
Pubmed	Expression of epidermal growth factors and a tight junction protein in the nasal mucosa of patients with chronic hypertrophic rhinitis.	ERBB2 ERBB4 EGFR	1.26e-07	5	82	3	23137868
Pubmed	Gene expression pattern of the epidermal growth factor receptor family and LRIG1 in renal cell carcinoma.	ERBB2 ERBB4 EGFR	1.26e-07	5	82	3	22554477
Pubmed	Developmental profile of ErbB receptors in murine central nervous system: implications for functional interactions.	ERBB2 ERBB4 EGFR	1.26e-07	5	82	3	15682390
Pubmed	Neuregulin-1 induces branching morphogenesis in the developing lung through a P13K signal pathway.	ERBB2 ERBB4 EGFR	1.26e-07	5	82	3	15524405
Pubmed	Segregation of receptor and ligand regulates activation of epithelial growth factor receptor.	ERBB2 ERBB4 EGFR	1.26e-07	5	82	3	12646923
Pubmed	Hepatitis C Virus Activates a Neuregulin-Driven Circuit to Modify Surface Expression of Growth Factor Receptors of the ErbB Family.	ERBB2 ERBB4 EGFR	1.26e-07	5	82	3	26886748
Pubmed	Localization of phosphorylated ErbB1-4 and heregulin in colorectal cancer.	ERBB2 ERBB4 EGFR	1.26e-07	5	82	3	25416285
Pubmed	Synapse-associated expression of an acetylcholine receptor-inducing protein, ARIA/heregulin, and its putative receptors, ErbB2 and ErbB3, in developing mammalian muscle.	ERBB2 ERBB4 EGFR	1.26e-07	5	82	3	7589796
Pubmed	Unraveling ERBB network dynamics upon betacellulin signaling in pancreatic ductal adenocarcinoma in mice.	ERBB2 ERBB4 EGFR	2.51e-07	6	82	3	32335999
Pubmed	The ectodomain of cadherin-11 binds to erbB2 and stimulates Akt phosphorylation to promote cranial neural crest cell migration.	ERBB2 ERBB4 EGFR	2.51e-07	6	82	3	29190819
Pubmed	LRIG1 restricts growth factor signaling by enhancing receptor ubiquitylation and degradation.	ERBB2 ERBB4 EGFR	2.51e-07	6	82	3	15282549
Pubmed	Transgenic MUC1 interacts with epidermal growth factor receptor and correlates with mitogen-activated protein kinase activation in the mouse mammary gland.	ERBB2 ERBB4 EGFR	2.51e-07	6	82	3	11278868
Pubmed	Modulation of Erbb2 signaling during development: a threshold level of Erbb2 signaling is required for development.	ERBB2 ERBB4 EGFR	2.51e-07	6	82	3	15496447
Pubmed	Mutational analysis of EGFR and related signaling pathway genes in lung adenocarcinomas identifies a novel somatic kinase domain mutation in FGFR4.	ERBB2 ERBB4 EGFR	4.39e-07	7	82	3	17487277
Pubmed	Neuregulin-1/ErbB4 signaling controls the migration of oligodendrocyte precursor cells during development.	ERBB2 ERBB4 EGFR	4.39e-07	7	82	3	22504067
Pubmed	A comprehensive study of the association between the EGFR and ERBB2 genes and glioma risk.	ERBB2 ERBB4 EGFR	4.39e-07	7	82	3	20446891
Pubmed	Stretch-induced fetal type II cell differentiation is mediated via ErbB1-ErbB4 interactions.	ERBB2 ERBB4 EGFR	4.39e-07	7	82	3	22493501
Pubmed	Vertebrate Lrig3-ErbB interactions occur in vitro but are unlikely to play a role in Lrig3-dependent inner ear morphogenesis.	ERBB2 ERBB4 EGFR	4.39e-07	7	82	3	20126551
Pubmed	Syndecan-1 and Syndecan-4 Capture Epidermal Growth Factor Receptor Family Members and the α3β1 Integrin Via Binding Sites in Their Ectodomains: NOVEL SYNSTATINS PREVENT KINASE CAPTURE AND INHIBIT α6β4-INTEGRIN-DEPENDENT EPITHELIAL CELL MOTILITY.	ERBB2 EGFR ITGA6	7.01e-07	8	82	3	26350464
Pubmed	Cytoplasmic domain interactions of syndecan-1 and syndecan-4 with α6β4 integrin mediate human epidermal growth factor receptor (HER1 and HER2)-dependent motility and survival.	ERBB2 EGFR ITGA6	7.01e-07	8	82	3	25202019
Pubmed	Dynamic expression of Erbb pathway members during early mammary gland morphogenesis.	ERBB2 ERBB4 EGFR	7.01e-07	8	82	3	17960183
Pubmed	Differential expression of neuregulins and their receptors in the olfactory bulb layers of the developing mouse.	ERBB2 ERBB4 EGFR	7.01e-07	8	82	3	16488402
Pubmed	Embryo-uterine interactions via the neuregulin family of growth factors during implantation in the mouse.	ERBB2 ERBB4 EGFR	7.01e-07	8	82	3	15306553
Pubmed	ERBB3-dependent AKT and ERK pathways are essential for atrioventricular cushion development in mouse embryos.	ERBB2 ERBB4 EGFR	1.05e-06	9	82	3	34714866
Pubmed	In situ hybridization reveals developmental regulation of ErbB1-4 mRNA expression in mouse midbrain: implication of ErbB receptors for dopaminergic neurons.	ERBB2 ERBB4 EGFR	1.50e-06	10	82	3	19298847
Pubmed	The epidermal growth factor receptor couples transforming growth factor-alpha, heparin-binding epidermal growth factor-like factor, and amphiregulin to Neu, ErbB-3, and ErbB-4.	ERBB2 ERBB4 EGFR	1.50e-06	10	82	3	8702723
Pubmed	Somatic mutations in epidermal growth factor receptor signaling pathway genes in non-small cell lung cancers.	ERBB2 ERBB4 EGFR	1.50e-06	10	82	3	20881644
Pubmed	Evidence for new homotypic and heterotypic interactions between transmembrane helices of proteins involved in receptor tyrosine kinase and neuropilin signaling.	ERBB2 ERBB4 EGFR	2.06e-06	11	82	3	25315821
Pubmed	Impaired migration and delayed differentiation of pancreatic islet cells in mice lacking EGF-receptors.	ERBB2 ERBB4 EGFR	2.06e-06	11	82	3	10821760
Pubmed	Altered trophoblast proliferation is insufficient to account for placental dysfunction in Egfr null embryos.	ERBB2 ERBB4 EGFR	2.06e-06	11	82	3	17822758
Pubmed	An EGFR-ERK-SOX9 signaling cascade links urothelial development and regeneration to cancer.	ERBB2 ERBB4 EGFR	3.55e-06	13	82	3	21512138
Pubmed	Defining a link with autosomal-dominant polycystic kidney disease in mice with congenitally low expression of Pkd1.	ERBB2 EGFR PKD1	4.51e-06	14	82	3	16400024
Pubmed	Impaired maturation of dendritic spines without disorganization of cortical cell layers in mice lacking NRG1/ErbB signaling in the central nervous system.	ERBB2 ERBB4 LAMA2	4.51e-06	14	82	3	19240213
Pubmed	Prognostic and predictive values of EGFR overexpression and EGFR copy number alteration in HER2-positive breast cancer.	ERBB2 EGFR	5.49e-06	2	82	2	25349977
Pubmed	Prognostic role of human epidermal growth factor receptor in gastric cancer: a systematic review and meta-analysis.	ERBB2 EGFR	5.49e-06	2	82	2	23871709
Pubmed	HER1 R497K and HER2 I655V polymorphisms are linked to development of breast cancer.	ERBB2 EGFR	5.49e-06	2	82	2	23594562
Pubmed	Identification of autophosphorylation sites of HER2/neu.	ERBB2 EGFR	5.49e-06	2	82	2	1706616
Pubmed	Effects of the combined blockade of EGFR and ErbB-2 on signal transduction and regulation of cell cycle regulatory proteins in breast cancer cells.	ERBB2 EGFR	5.49e-06	2	82	2	19946741
Pubmed	EGFR and ERBB2 Exon 20 Insertion Mutations in Chinese Non-small Cell Lung Cancer Patients: Pathological and Molecular Characterization, and First-Line Systemic Treatment Evaluation.	ERBB2 EGFR	5.49e-06	2	82	2	38416376
Pubmed	Evolutionary analysis of the ErbB receptor and ligand families.	ERBB2 EGFR	5.49e-06	2	82	2	10824084
Pubmed	Genetic and expression analysis of HER-2 and EGFR genes in salivary duct carcinoma: empirical and therapeutic significance.	ERBB2 EGFR	5.49e-06	2	82	2	20371674
Pubmed	Epidermal growth factor receptor status in breast cancer metastases to the central nervous system. Comparison with HER-2/neu status.	ERBB2 EGFR	5.49e-06	2	82	2	15335267
Pubmed	Significance of epidermal growth factor receptor expression in breast cancer.	ERBB2 EGFR	5.49e-06	2	82	2	21104342
Pubmed	ERF: genomic organization, chromosomal localization and promoter analysis of the human and mouse genes.	ERF PRKCG	5.49e-06	2	82	2	9136988
Pubmed	Her4 and Her2/neu tyrosine kinase domains dimerize and activate in a reconstituted in vitro system.	ERBB2 ERBB4	5.49e-06	2	82	2	20022944
Pubmed	Synergistic Blockade of EGFR and HER2 by New-Generation EGFR Tyrosine Kinase Inhibitor Enhances Radiation Effect in Bladder Cancer Cells.	ERBB2 EGFR	5.49e-06	2	82	2	25589492
Pubmed	Protein overexpression and gene amplification of HER-2 and EGFR in colorectal cancers: an immunohistochemical and fluorescent in situ hybridization study.	ERBB2 EGFR	5.49e-06	2	82	2	15143334
Pubmed	An EGFR/HER2-Bispecific and enediyne-energized fusion protein shows high efficacy against esophageal cancer.	ERBB2 EGFR	5.49e-06	2	82	2	24664246
Pubmed	Impact of common epidermal growth factor receptor and HER2 variants on receptor activity and inhibition by lapatinib.	ERBB2 EGFR	5.49e-06	2	82	2	18199554
Pubmed	Status of HER1 and HER2 in peritoneal, ovarian and colorectal endometriosis and ovarian endometrioid adenocarcinoma.	ERBB2 EGFR	5.49e-06	2	82	2	19294416
Pubmed	Expression of erbB-1 and erbB-2 genes in normal and pathological human endometrium.	ERBB2 EGFR	5.49e-06	2	82	2	17549377
Pubmed	Prognostic implications of EGFR and HER-2 alteration assessed by immunohistochemistry and silver in situ hybridization in gastric cancer patients following curative resection.	ERBB2 EGFR	5.49e-06	2	82	2	23955257
Pubmed	Cooverexpression of ERBB1 and ERBB4 receptors predicts poor clinical outcome in pN+ oral squamous cell carcinoma with extranodal spread.	ERBB4 EGFR	5.49e-06	2	82	2	24338375
Pubmed	The efficient elimination of solid tumor cells by EGFR-specific and HER2-specific scFv-SNAP fusion proteins conjugated to benzylguanine-modified auristatin F.	ERBB2 EGFR	5.49e-06	2	82	2	27502168
Pubmed	Frequent genetic alterations in EGFR- and HER2-driven pathways in breast cancer brain metastases.	ERBB2 EGFR	5.49e-06	2	82	2	23665199
Pubmed	Epidermal growth factor receptor activity is necessary for mouse basal cell proliferation.	ERBB2 EGFR	5.49e-06	2	82	2	25217659
Pubmed	EGFR and HER2 expression in advanced biliary tract cancer.	ERBB2 EGFR	5.49e-06	2	82	2	19777609
Pubmed	Neuregulin receptors erbB2 and erbB4 in failing human myocardium -- depressed expression and attenuated activation.	ERBB2 ERBB4	5.49e-06	2	82	2	15685397
Pubmed	Differential cytoskeletal association of ErbB1 and ErbB2 during keratinocyte differentiation.	ERBB2 EGFR	5.49e-06	2	82	2	12135609
Pubmed	Dual inhibition of ErbB1 and ErbB2 in cancer by recombinant human prolidase mutant hPEPD-G278D.	ERBB2 EGFR	5.49e-06	2	82	2	27286447
Pubmed	Increased concentrations of growth factors and activation of the EGFR system in breast cancer.	ERBB2 EGFR	5.49e-06	2	82	2	23089711
Pubmed	EGFR Expression in HER2-Driven Breast Cancer Cells.	ERBB2 EGFR	5.49e-06	2	82	2	33260837
Pubmed	Membrane-bound trafficking regulates nuclear transport of integral epidermal growth factor receptor (EGFR) and ErbB-2.	ERBB2 EGFR	5.49e-06	2	82	2	22451678
Pubmed	The immune microenvironment in EGFR- and ERBB2-mutated lung adenocarcinoma.	ERBB2 EGFR	5.49e-06	2	82	2	34487971
Pubmed	Screening and validation of dinucleotide repeats in intron 1 of the human EGFR gene and its paralog in the HER2 gene.	ERBB2 EGFR	5.49e-06	2	82	2	18946768
Pubmed	Dissecting the molecular recognition of dual lapatinib derivatives for EGFR/HER2.	ERBB2 EGFR	5.49e-06	2	82	2	31828486
Pubmed	Design, biological evaluation and 3D QSAR studies of novel dioxin-containing pyrazoline derivatives with thiourea skeleton as selective HER-2 inhibitors.	ERBB2 EGFR	5.49e-06	2	82	2	27273260
Pubmed	Association of EGFR and HER2 polymorphisms with risk and clinical features of thyroid cancer.	ERBB2 EGFR	5.49e-06	2	82	2	19860576
Pubmed	Androgen receptor controls EGFR and ERBB2 gene expression at different levels in prostate cancer cell lines.	ERBB2 EGFR	5.49e-06	2	82	2	19318561
Pubmed	Induction of cancer cell migration by epidermal growth factor is initiated by specific phosphorylation of tyrosine 1248 of c-erbB-2 receptor via EGFR.	ERBB2 EGFR	5.49e-06	2	82	2	12354693
Interaction	MUC4 interactions	ERBB2 ERBB4 EGFR	5.16e-06	9	81	3	int:MUC4
Interaction	PTPRT interactions	ERBB2 ERBB4 EGFR	1.01e-05	11	81	3	int:PTPRT
Cytoband	3p25	BTD CAV3	4.21e-04	17	82	2	3p25
GeneFamily	Erb-b2 receptor tyrosine kinases	ERBB2 ERBB4 EGFR	7.95e-08	4	50	3	1096
GeneFamily	Solute carriers	SLC6A13 SLC9A5 SLC2A9 SLC6A16 SLC25A14 SLC25A30	7.38e-04	395	50	6	752
GeneFamily	Fibronectin type III domain containing	ROBO4 CNTN5 IGSF9 CDON	9.91e-04	160	50	4	555
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	ROBO4 CNTN5 IGSF9 CDON	1.01e-03	161	50	4	593
GeneFamily	Zinc fingers ZZ-type\|Lysine acetyltransferases	TADA2B HERC2	1.11e-03	18	50	2	91
GeneFamily	Hyalectan proteoglycans\|V-set domain containing\|Sushi domain containing\|C-type lectin domain containing	CD93 PKD1	5.74e-03	41	50	2	1298
CoexpressionAtlas	thyroid gland	RAP1GAP CNTN5 TLE6 OVCH1 MPPED2 PKHD1L1 CDON	3.40e-05	240	80	7	thyroid gland
CoexpressionAtlas	alpha beta T cells, T.4Nve.LN, 4+ 8- 25- 62Lhi 44lo, Lymph Node, avg-3	CRIM1 ZNRF3 PACSIN1 PRF1 ITGA6 MARK2 CDON TECPR1	3.89e-05	336	80	8	GSM538374_500
CoexpressionAtlas	alpha beta T cells, T.4.PLN.BDC, 4+ 8- BDC+, Lymph Node, avg-3	CRIM1 ZNRF3 PACSIN1 ITGA6 MARK2 IL17RB CDON TECPR1	3.89e-05	336	80	8	GSM605758_500
CoexpressionAtlas	alpha beta T cells, T.4.TI.B16, 4+ 8- TCR+ 45+, B16 Melanoma Tumor, avg-3	CRIM1 ZNRF3 PACSIN1 PRF1 ITGA6 MARK2 CDON TECPR1	4.06e-05	338	80	8	GSM605763_500
CoexpressionAtlas	facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K2	SLC6A13 CTSF RAP1GAP GALM EGFR NYNRIN PKD1 BACE1 TLE6 ALPK1 IDH2 GK5 MPPED2 BAIAP2L2 CDON	4.73e-05	1228	80	15	facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K2
CoexpressionAtlas	alpha beta T cells, NKT.4+.Lv, CD45 TCRb aGalCer-loaded CD1d tet CD4, Liver, avg-4	CD93 CRIM1 ZNRF3 PRF1 PPP1R15A IL17RB CDON TECPR1	5.19e-05	350	80	8	GSM538318_500
CoexpressionAtlas	alpha beta T cells, NKT.4-.Lv, CD45 TCRb aGalCer-loaded CD1d tet, Liver, avg-4	CD93 CRIM1 ZNRF3 PRF1 PPP1R15A IL17RB CDON TECPR1	5.30e-05	351	80	8	GSM538325_500
CoexpressionAtlas	alpha beta T cells, T.4.LN.BDC, 4+ 8- BDC+, Lymph Node, avg-3	CRIM1 ZNRF3 PACSIN1 PRF1 ITGA6 MARK2 IL17RB TECPR1	5.62e-05	354	80	8	GSM605753_500
CoexpressionAtlas	alpha beta T cells, T.8Nve.MLN, 4- 8+ 25- 62Lhi 44lo, Lymph Node, avg-3	MDN1 CRIM1 ZNRF3 PACSIN1 PRF1 BACE1 MARK2 TECPR1	5.85e-05	356	80	8	GSM538409_500
CoexpressionAtlas	CD positive, CD4 Test JS, 4+8-B220-, Spleen, avg-3	CRIM1 ZNRF3 PACSIN1 PRF1 ITGA6 MARK2 CDON TECPR1	6.20e-05	359	80	8	GSM404000_500
CoexpressionAtlas	alpha beta T cells, T.4FP3-.Sp, 4+ 8- GFP- 44lo, Spleen, avg-3	CRIM1 ZNRF3 PACSIN1 PRF1 ITGA6 MARK2 CDON TECPR1	6.83e-05	364	80	8	GSM605766_500
CoexpressionAtlas	alpha beta T cells, T.8Mem.Sp, 4- 8+ 25- 44hi 122hi, Spleen, avg-3	MDN1 CRIM1 ZNRF3 PACSIN1 PRF1 CRYBG1 TECPR1	1.47e-04	303	80	7	GSM538398_500
CoexpressionAtlas	alpha beta T cells, T.4Nve.PP, TCR+ CD4+ CD44low CD62Lhigh, Peyer's Patch, avg-2	MDN1 ZNRF3 PACSIN1 ITGA6 CRYBG1 PPP1R15A TECPR1	2.34e-04	327	80	7	GSM538380_500
CoexpressionAtlas	alpha beta T cells, T.8Nve.LN, 4- 8+ 25- 62Lhi 44lo, Lymph Node, avg-3	CRIM1 ZNRF3 PACSIN1 PRF1 ITGA6 MARK2 TECPR1	2.66e-04	334	80	7	GSM538406_500
CoexpressionAtlas	alpha beta T cells, T.8.Sp.B16, 4- 8+ TCR+ 45+, B16 Melanoma Spleen, avg-3	MDN1 CRIM1 ZNRF3 PACSIN1 PRF1 ITGA6 TECPR1	2.71e-04	335	80	7	GSM605770_500
CoexpressionAtlas	CD positive, CD4 Test DB, 4+8-B220-, Spleen, avg-1	MDN1 CRIM1 ZNRF3 PACSIN1 PRF1 ITGA6 TECPR1	2.86e-04	338	80	7	GSM403987_500
CoexpressionAtlas	alpha beta T cells, T.4Mem.Sp, 4+ 8- 25- 44hi 122lo, Spleen, avg-3	GALM CRIM1 PACSIN1 ITGA6 IL17RB CDON TECPR1	3.12e-04	343	80	7	GSM538365_500
CoexpressionAtlas	CD positive, CD4 Test NA, 4+8-B220-, Spleen, avg-1	CRIM1 ZNRF3 PACSIN1 PRF1 ITGA6 CDON TECPR1	3.97e-04	357	80	7	GSM403986_500
CoexpressionAtlas	alpha beta T cells, T.4SP24-.Th, 4+ 8- TCRhi 24-/lo, Thymus, avg-3	ZNRF3 PACSIN1 ITGA6 CRYBG1 MARK2 CDON TECPR1	4.53e-04	365	80	7	GSM399370_500
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SLC6A13 GALM SLC2A9 CDHR5 ABCC6 BAIAP2L2 IL17RB	5.59e-08	187	82	7	1b82920588f9e26ef1db244d452736d75fcfd342
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SLC6A13 GALM SLC2A9 CDHR5 ABCC6 BAIAP2L2 IL17RB	5.59e-08	187	82	7	c1e4c0345f9bfa0538730bad5ff3fa5240168b25
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SLC6A13 GALM SLC2A9 CDHR5 ABCC6 BAIAP2L2	1.24e-06	186	82	6	a417e1e21313a7e05951038cdef5ac672a9f727c
ToppCell	356C-Endothelial_cells-Endothelial-E-\|356C / Donor, Lineage, Cell class and subclass (all cells)	CD93 CRIM1 S100A16 IDO1 ITGA6 TECPR1	1.24e-06	186	82	6	2e024097ee361eeb1d855a4edb8ac8cdad35da06
ToppCell	356C-Endothelial_cells-Endothelial-E\|356C / Donor, Lineage, Cell class and subclass (all cells)	CD93 CRIM1 S100A16 IDO1 ITGA6 TECPR1	1.24e-06	186	82	6	c3449e54454009973818fc1101933c6f0168258c
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SLC6A13 CMIP SLC2A9 CNTN5 ITGA6 CDHR5	1.24e-06	186	82	6	b1edc341d6684b347dc9e21b34f62f51d095d735
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SLC6A13 GALM SLC2A9 CDHR5 ABCC6 IL17RB	1.28e-06	187	82	6	71eb26ebf60cb0848e5bf1cd01edccda621aecd8
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SLC6A13 GALM SLC2A9 CDHR5 ABCC6 IL17RB	1.32e-06	188	82	6	f3edcefeef2ce19086032d98b243c02a6d542b38
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SLC6A13 GALM SLC2A9 CDHR5 ABCC6 IL17RB	1.32e-06	188	82	6	0792432cd4c564dea1102241ea9884f7ced7658c
ToppCell	Parenchyma_COVID-19-Endothelial-TX-Endothelial-2\|Parenchyma_COVID-19 / Sample group, Lineage and Cell type	CD93 ROBO4 IDO1 BTNL3 BEX5 ITGA6	1.84e-06	199	82	6	edb68a4f622a494f22fd7b25bc40ae0d58456cdb
ToppCell	Lung_Parenchyma-Severe-Endothelial-Endothelial-Endothelial-2\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CD93 ROBO4 IDO1 BTNL3 BEX5 ITGA6	1.84e-06	199	82	6	448dd5a27d57627468c6b8347f1b6b1005aea004
ToppCell	Lung_Parenchyma-Severe-Endothelial-Endothelial-Endothelial-2-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CD93 ROBO4 IDO1 BTNL3 BEX5 ITGA6	1.84e-06	199	82	6	45f9c03d2ed2d98d66086fb0251bd24e30c6f775
ToppCell	VE-CD8-memory_CD4\|VE / Condition, Cell_class and T cell subcluster	RCC1L PRF1 ITGA6 LMOD2 SCN3B	9.12e-06	152	82	5	9401b7770c1bdc87eba25e82922f5dd1c4fa37ee
ToppCell	PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_prolif\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CD93 ROBO4 S100A16 IDO1 SCN3B	1.07e-05	157	82	5	2c946c6ab284fac3c25db688ed0aabe5a3f9ffa5
ToppCell	PND01-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_mature\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CD93 ROBO4 S100A16 SLC25A30 SCN3B	1.48e-05	168	82	5	55c9de7b3a1d6cf7b02b020ff92ab4ede8d195cc
ToppCell	NS-critical-d_0-4-Epithelial-Secretory\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ERBB2 CTSF RAP1GAP EGFR IGSF9	1.52e-05	169	82	5	aec97583b23112060437b619cb429dc32f29285f
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Degenerative_Medullary_Thick_Ascending_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	USP2 ERBB4 RAP1GAP NYNRIN CASK	1.70e-05	173	82	5	7a3115e7cf7e2f345192cde0656a7f0193594a5f
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SLC6A13 GALM SLC2A9 CDHR5 ABCC6	1.85e-05	176	82	5	1595dbeee336a81e581325d63208ec6262664ee9
ToppCell	PND07-28-samps-Endothelial-Postnatal_endothelial-endothelial_cells_C\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	CD93 ROBO4 S100A16 IDO1 TECPR1	1.90e-05	177	82	5	6da88c358b3a2e47fa3472217a38b6b00ad7b280
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SLC6A13 SLC2A9 CDHR5 ABCC6 IL17RB	2.17e-05	182	82	5	e1e58176f533092b6b974ca1ce8b02192a6e193d
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SLC6A13 SLC2A9 CDHR5 ABCC6 IL17RB	2.17e-05	182	82	5	4a9c13932e7163fd37a3dcc4c6ca3bbea5372459
ToppCell	P28-Endothelial-capillary_endothelial_cell-capillary_endothelial_cell\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	CD93 S100A16 ITGA6 PPP1R15A SCN3B	2.17e-05	182	82	5	db5d6c5e7d59734653906b126f2c1d57461a5290
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SLC6A13 SLC2A9 CDHR5 ABCC6 IL17RB	2.17e-05	182	82	5	57bb5a2da976464ba7c4460106bd9f692008ebd9
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SLC6A13 SLC2A9 CDHR5 ABCC6 IL17RB	2.23e-05	183	82	5	84b64cf728629c3af9a8d2ed15b93adf562c54b8
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SLC6A13 GALM SLC2A9 CDHR5 BAIAP2L2	2.29e-05	184	82	5	9434731f651820b05335085582960f08fbf895de
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SLC6A13 GALM SLC2A9 CDHR5 ABCC6	2.41e-05	186	82	5	8287146f0ba415ea04475588117d4668ae00f75c
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	USP2 SLC6A13 CMIP SLC2A9 ZNRF3	2.41e-05	186	82	5	5784d255e9ca449d375d81938d0fbbd8a7eb44f6
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	USP2 ERBB4 RAP1GAP LTBP2 IDH2	2.48e-05	187	82	5	b93cf4dfe8ffb89348ee7bccc9f284189f7240a2
ToppCell	E17.5-Endothelial-capillary_endothelial_cell-capillary_endothelial_cell\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	CD93 ROBO4 S100A16 ITGA6 SCN3B	2.48e-05	187	82	5	e9aa0a5a0f8e2593de63e83b56b53ae33e60af49
ToppCell	E17.5-Endothelial-unknown_endothelial_cell\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	CD93 ROBO4 S100A16 MPPED2 SCN3B	2.48e-05	187	82	5	da885c26ccc5189b1ff1f607552e00a5c0e49e7e
ToppCell	E17.5-Endothelial-capillary_endothelial_cell\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	CD93 ROBO4 S100A16 ITGA6 SCN3B	2.48e-05	187	82	5	61b8a53f29bb8b33c69f680b8359a1143a23999d
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CD93 ROBO4 S100A16 ITGA6 TECPR1	2.48e-05	187	82	5	0ef82111b9049cc7ee78d64d240e1f10ab14d6b6
ToppCell	E17.5-Endothelial-unknown_endothelial_cell-endothelial_unknown_1\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	CD93 ROBO4 S100A16 MPPED2 SCN3B	2.48e-05	187	82	5	1f358d02ec69d44dea2e2831af9473ed05dcf8cc
ToppCell	Thalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn_(Dcn)\|Thalamus / BrainAtlas - Mouse McCarroll V32	SLC6A13 CRYGS PRF1 LOXL4	2.53e-05	92	82	4	bbaf5a131f860198840e34843b7c841bcc98d9c4
ToppCell	Thalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn_(Dcn)-\|Thalamus / BrainAtlas - Mouse McCarroll V32	SLC6A13 CRYGS PRF1 LOXL4	2.53e-05	92	82	4	e6aa2b8ca9235a7291ee41d976b886fec185835d
ToppCell	P28-Endothelial-large_vessel_endothelial_cell\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	CD93 CMIP CRIM1 S100A16 PPP1R15A	2.54e-05	188	82	5	263169029293e005bcffd87db20221fdd2d3917e
ToppCell	5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CTSF SLC2A9 EGFR LAMA2 LTBP2	2.60e-05	189	82	5	f7d57723b8fb0f1e1485f51e3eff93ec0f39761e
ToppCell	P07-Endothelial-unknown_endothelial_cell-endothelial_unknown_1\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	CD93 S100A16 MPPED2 SCN3B TECPR1	2.60e-05	189	82	5	fcfb28bd96471affc13e55aa7228f594aaa967cd
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SLC6A13 GALM SLC2A9 ABCC6 IL17RB	2.60e-05	189	82	5	13fd07cc408a9486f61a7b2c3a132c52d14b438d
ToppCell	P07-Endothelial-unknown_endothelial_cell\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	CD93 S100A16 MPPED2 SCN3B TECPR1	2.60e-05	189	82	5	f515a04ae1746257d4568cea13a3dd75b4b05275
ToppCell	Control-Endothelial-VE_Capillary_B\|Endothelial / Disease state, Lineage and Cell class	CD93 EGFR BEX5 LAMA2 ITGA6	2.67e-05	190	82	5	7f3f419fffe02934b6f27b697f7a6401072491ed
ToppCell	COPD-Lymphoid-T_Cytotoxic\|Lymphoid / Disease state, Lineage and Cell class	CMIP GALM PRF1 AOAH CRYBG1	2.67e-05	190	82	5	10bece40d980d37a01dae8ce887655bf9f93040c
ToppCell	facs-MAT-Fat-18m-Endothelial\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD93 ROBO4 CRIM1 ITGA6 CDHR5	2.67e-05	190	82	5	34e56c5e7ea6a8f227dbaefe73cbb8818d18b523
ToppCell	facs-MAT-Fat-18m-Endothelial-nan\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD93 ROBO4 CRIM1 ITGA6 CDHR5	2.67e-05	190	82	5	14cdb660ad3aabcf49572173e7628d8b99dcbe6f
ToppCell	(2)_Fibroblasts-(21)_Fibro-2\|(2)_Fibroblasts / Cell class and subclass of bone marrow stroma cells in homeostatis	S100A16 EGFR ITGA6 CDHR5 DNASE2	2.67e-05	190	82	5	d2afa08ad868acc6fce308ec21b0bf93591d4010
ToppCell	E17.5-Endothelial\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	CD93 ROBO4 S100A16 ITGA6 SCN3B	2.67e-05	190	82	5	4fb76195ec9d6e0260a628eef6c2b3705acce787
ToppCell	PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CD93 ROBO4 S100A16 ITGA6 SCN3B	2.67e-05	190	82	5	6847afca73e1b76c2e86187ccb1a164aefd8f17b
ToppCell	facs-MAT-Fat-18m-Endothelial-endothelial_cell\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD93 ROBO4 CRIM1 ITGA6 CDHR5	2.67e-05	190	82	5	9aaa48f3aad813c87a45efdbb67d255c94f6e6a4
ToppCell	facs-Lung-3m-Endothelial-capillary_endothelial-capillary_endothelial_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CD93 ROBO4 S100A16 ITGA6 SCN3B	2.74e-05	191	82	5	38fe60a8570f3c6eb8e8f8646f90d505dfd7d647
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Degenerative_Medullary_Thick_Ascending_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	USP2 ERBB4 RAP1GAP LTBP2 IDH2	2.74e-05	191	82	5	f631749ef1f2270133664cf5eb4cf545a8482bd3
ToppCell	facs-Lung-3m-Endothelial-capillary_endothelial\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CD93 ROBO4 S100A16 ITGA6 SCN3B	2.74e-05	191	82	5	0e6cd2628a5cebd35e960e4eb3b52ddc9358031c
ToppCell	(2)_Fibroblasts-(21)_Fibro-2\|World / Cell class and subclass of bone marrow stroma cells in homeostatis	EGFR ITGA6 CDHR5 DNASE2 CDON	2.74e-05	191	82	5	5ee353c79055c08e8a3e2b43a0345bceb09f3890
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	GALM ITGA6 CRYBG1 PPP1R15A CASK	2.74e-05	191	82	5	142f98cabf8737b28369315b3d7a0797ded88e03
ToppCell	RA-09._Endothelium_I\|World / Chamber and Cluster_Paper	ROBO4 CMIP CRIM1 ITGA6 PKHD1L1	2.74e-05	191	82	5	c8a0c2af119bc34a8f694a7d30642f28002c84b9
ToppCell	droplet-Kidney-nan-18m-Epithelial-Epcam____thick_ascending_tube_S_epithelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ERBB4 RAP1GAP ITGA6 IDH2 BAIAP2L2	2.81e-05	192	82	5	e19e3e8edcc08e4a67873bfb6e46489ca6c8756a
ToppCell	PCW_07-8.5-Endothelial-Endothelial_cycling-endo_proliferating2_(14)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	CD93 ROBO4 S100A16 ITGA6 SCN3B	2.81e-05	192	82	5	ac3d87aa301d30515c369bd7fc16f33b82173a85
ToppCell	Endothelial-A\|World / shred on cell class and cell subclass (v4)	CD93 ROBO4 S100A16 ITGA6 SCN3B	2.81e-05	192	82	5	9919cdc0ce833894525dba429f251ea1b094fbd8
ToppCell	E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CD93 ROBO4 S100A16 ITGA6 SCN3B	2.81e-05	192	82	5	1a3f24607cb49aa610c183f4c2b7d735f484a3a4
ToppCell	Endothelial\|World / shred on cell class and cell subclass (v4)	CD93 ROBO4 S100A16 ITGA6 SCN3B	2.81e-05	192	82	5	2b13cca5c4b58628dbbbb356859632dba66d43f9
ToppCell	droplet-Kidney-nan-18m-Epithelial-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ERBB4 RAP1GAP ITGA6 IDH2 BAIAP2L2	2.81e-05	192	82	5	61c2caf6c838132ed5faa8791c288f2149eba2c8
ToppCell	droplet-Lung-3m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_endothelial_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CD93 ROBO4 S100A16 ITGA6 SCN3B	2.81e-05	192	82	5	6b69bb8fab9b470850eba1a070a500435ec233cd
ToppCell	E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CD93 ROBO4 S100A16 ITGA6 SCN3B	2.81e-05	192	82	5	c8dcd75d695d09adff083af8d5a64cf15fe027d4
ToppCell	PCW_07-8.5-Endothelial-Endothelial_immature-endo_immature_arterial1_(12)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	CD93 ROBO4 S100A16 CRYBG1 SCN3B	2.88e-05	193	82	5	d338a7c0585b69947c37f44aa0381619493e31ea
ToppCell	droplet-Lung-nan-3m-Endothelial-Capillary_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD93 ROBO4 S100A16 ITGA6 SCN3B	2.88e-05	193	82	5	7cff1e859b296b1032eebcfc0f99a504f3bda2c9
ToppCell	IPF-Lymphoid-T_Cytotoxic\|Lymphoid / Disease state, Lineage and Cell class	CMIP GALM PRF1 AOAH CRYBG1	2.88e-05	193	82	5	3c8a022dbd4f8d25b14fd137ce64c2713a7dbe41
ToppCell	E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CD93 ROBO4 S100A16 ITGA6 SCN3B	2.88e-05	193	82	5	f4dd52491254ce321bc4d0dad988a7ce5970f52d
ToppCell	PND10-Endothelial-Endothelial_blood-vessel\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CD93 ROBO4 S100A16 ITGA6 SCN3B	2.88e-05	193	82	5	1d8acf81dcbfe81c7a73ce50c9f38fe0cbc74486
ToppCell	PND01-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CD93 ROBO4 S100A16 ITGA6 SCN3B	2.88e-05	193	82	5	b7c0b4dbbe11f86cff6371d3d12a6b772b938d78
ToppCell	droplet-Lung-3m-Endothelial\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CD93 ROBO4 S100A16 ITGA6 SCN3B	2.88e-05	193	82	5	95c9c63bddfed1a84393ccd3578cfe65bc0c1c05
ToppCell	PND01-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CD93 ROBO4 S100A16 ITGA6 SCN3B	2.88e-05	193	82	5	e44d777f65b907f299cefd73296805ac4c92d383
ToppCell	P15-Endothelial-large_vessel_endothelial_cell\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	CD93 CMIP CRIM1 S100A16 PPP1R15A	2.88e-05	193	82	5	5f9a7cd5f8eb9ac294cdb50518fedf872f3f78f5
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CD93 ROBO4 S100A16 ITGA6 SCN3B	2.88e-05	193	82	5	097a244cf37ce6c1ace9bae56beb7de59442cd6b
ToppCell	PND10-Endothelial\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CD93 ROBO4 S100A16 ITGA6 SCN3B	2.88e-05	193	82	5	f3c743b340fc588bc8effd375b12e2c7cbfa49d2
ToppCell	PND14-Endothelial\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CD93 ROBO4 S100A16 ITGA6 SCN3B	2.95e-05	194	82	5	cee89d4340738f09d07a159cd6aeee4300776988
ToppCell	droplet-Lung-1m-Endothelial-capillary_endothelial-capillary_endothelial_cell\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CD93 ROBO4 S100A16 MPPED2 SCN3B	2.95e-05	194	82	5	e13923860a64ba9cf32df53c9f0cf4e7c321881d
ToppCell	PND14-Endothelial-Endothelial_blood-vessel\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CD93 ROBO4 S100A16 ITGA6 SCN3B	2.95e-05	194	82	5	32962060d80f3edffbe9f0ecad3000c3a9817865
ToppCell	PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CD93 ROBO4 S100A16 ITGA6 SCN3B	2.95e-05	194	82	5	2c78e754cac848fd47172f94e392749eb0ab50d4
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CD93 ROBO4 S100A16 ITGA6 SCN3B	2.95e-05	194	82	5	1b382508453c5b08fb617f626b230adf3b6cff99
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	CRIM1 PACSIN1 PRF1 AOAH IDH2	2.95e-05	194	82	5	b0a7f5ca0c6f4f5764a8b35b5de80d82b828c66c
ToppCell	PND07-Endothelial-Endothelial_blood-vessel\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CD93 ROBO4 S100A16 ITGA6 SCN3B	2.95e-05	194	82	5	12496bc964d1c572241410524a89ca1a9fdb7e34
ToppCell	PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CD93 ROBO4 S100A16 ITGA6 SCN3B	2.95e-05	194	82	5	92a8e6e3e3f6fd9dacb723b58e7a8b63473e403e
ToppCell	PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CD93 ROBO4 S100A16 ITGA6 SCN3B	2.95e-05	194	82	5	46e36817fd1ed27af8013375214c38c9a9271640
ToppCell	PND07-Endothelial\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CD93 ROBO4 S100A16 ITGA6 SCN3B	2.95e-05	194	82	5	d1080c86884916c22894b27994141463f5919812
ToppCell	COPD-Endothelial-VE_Capillary_B\|COPD / Disease state, Lineage and Cell class	CD93 ROBO4 S100A16 EGFR ITGA6	2.95e-05	194	82	5	18b7f901c12ca4f21f9a1eafd092aefe4d668b6d
ToppCell	PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CD93 ROBO4 S100A16 ITGA6 SCN3B	2.95e-05	194	82	5	c6cee7d15af76f9a60d7f414ef0bcc1735c47b7a
ToppCell	PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CD93 ROBO4 S100A16 ITGA6 SCN3B	2.95e-05	194	82	5	44c7d4b75f3b7c9301eba20610e548a01a84ae40
ToppCell	PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CD93 ROBO4 S100A16 ITGA6 SCN3B	2.95e-05	194	82	5	7f24023df47935286f185dd428d48797daf26f49
ToppCell	droplet-Lung-1m-Endothelial-capillary_endothelial\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CD93 ROBO4 S100A16 MPPED2 SCN3B	2.95e-05	194	82	5	86508dd9b9d345b6624d185048cc92b81dd11c2a
ToppCell	367C-Endothelial_cells-Endothelial-E-\|367C / Donor, Lineage, Cell class and subclass (all cells)	CD93 ROBO4 S100A16 BEX5 ITGA6	3.02e-05	195	82	5	65fc50e3818e902028fc4226070fa57609c66b9c
ToppCell	367C-Endothelial_cells-Endothelial-E\|367C / Donor, Lineage, Cell class and subclass (all cells)	CD93 ROBO4 S100A16 BEX5 ITGA6	3.02e-05	195	82	5	3b79e6bb525b17192ecec9e1227a29c419968144
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CD93 ROBO4 S100A16 ITGA6 SCN3B	3.02e-05	195	82	5	cd011433b3b9bfb1adb13eca2f3f2a5db024cd94
ToppCell	PCW_13-14-Endothelial-Endothelial_immature-endo_immature2_(1)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	CD93 ROBO4 S100A16 ITGA6 SCN3B	3.10e-05	196	82	5	b0288e28a6e6222a9e310eb6fe228c04b618db13
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	USP2 ERBB4 RAP1GAP IDH2 CASK	3.10e-05	196	82	5	1bfc3c85ce9501f52a912e53cbded7de74572b9d
ToppCell	Fetal_29-31_weeks-Endothelial\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CD93 ROBO4 ITGA6 PKHD1L1 SCN3B	3.10e-05	196	82	5	3981f6c7487598f4f7ce4650ac0ac5bd41481d66
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	USP2 ERBB4 RAP1GAP IDH2 CASK	3.10e-05	196	82	5	e02301642243df483fd066d978317c113c04692b
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Endothelial\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CD93 ROBO4 S100A16 ITGA6 PKHD1L1	3.10e-05	196	82	5	629236f95c838a473b5964a49b7c1b7ad863ea12
ToppCell	Parenchyma_Control_(B.)-Endothelial-TX-Endothelial-1\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	CD93 ROBO4 CRIM1 ITGA6 PKHD1L1	3.18e-05	197	82	5	f969685dee212f33a6f09e54c0cd1fd24ffef546
ToppCell	Lung_Parenchyma-Control-Endothelial-Endothelial-Endothelial-1\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	CD93 ROBO4 CRIM1 ITGA6 PKHD1L1	3.18e-05	197	82	5	1a137af40697137bb9d2b5caf2b1ffda55f04461
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	USP2 ERBB4 RAP1GAP LTBP2 IDH2	3.18e-05	197	82	5	4ea3f57cd88b8a6bb7cb4b9e3545c0fa8f331886
ToppCell	distal-Endothelial-Bronchial_Vessel_1-1\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CD93 ROBO4 CMIP CRIM1 S100A16	3.18e-05	197	82	5	0d1afd1ad7489c071db08b3dfff598423097d7e0
Drug	pyrido[3,4-d]pyrimidine	ERBB2 ERBB4 EGFR	4.34e-08	3	81	3	CID014758064
Drug	amiloride	ERBB2 ERBB4 SLC9A5 RNLS EGFR PKD1 LOXL4 PRKCG CNGA2 SCN3B	1.76e-07	315	81	10	CID000016230
Drug	6-(methylamino)pyrido(3,4-d)pyrimidine	ERBB2 ERBB4 EGFR	5.11e-06	10	81	3	ctd:C107875
Drug	BE-23372M	ERBB2 ERBB4 EGFR	7.01e-06	11	81	3	CID005311105
Drug	Tapi	ERBB2 EGFR PRF1 BACE1 MARK2	9.81e-06	80	81	5	CID003035404
Drug	CMF regimen	ERBB2 EGFR IDO1	1.21e-05	13	81	3	ctd:C034456
Drug	AC1L9JR2	ERBB4 ERF EGFR	1.21e-05	13	81	3	CID000446506
Drug	N-(2-(4-((3-chloro-4-(3-(trifluoromethyl)phenoxy)phenyl)amino)-5H-pyrrolo(3,2-d)pyrimidin-5-yl)ethyl)-3-hydroxy-3-methylbutanamide	ERBB2 EGFR	1.25e-05	2	81	2	ctd:C570404
Drug	Lapatinib	ERBB2 EGFR	1.25e-05	2	81	2	DB01259
Drug	AG213	ERBB4 EGFR CNTN5 ITGA6 PRKCG	1.65e-05	89	81	5	CID005328803
Drug	amoxapine	SLC6A13 RNLS SLC6A16 LOXL4	2.16e-05	46	81	4	CID000002170
Drug	nitecapone	RNLS ITGA6 LOXL4	2.35e-05	16	81	3	CID005464105
Drug	4-anilinoquinazoline	ERBB2 ERBB4 EGFR	2.35e-05	16	81	3	CID000324081
Drug	4-HT	ERBB2 ERBB4 EGFR ACO2 ITGA6	3.68e-05	105	81	5	CID005284643
Drug	5-iodonicotinic acid	ERBB2 EGFR	3.74e-05	3	81	2	CID000151950
Drug	2-acetamidoethanethiol	ERBB2 EGFR	3.74e-05	3	81	2	ctd:C023704
Drug	4557 W	ERBB2 EGFR	3.74e-05	3	81	2	ctd:C433938
Drug	4-aminopyrimidine-5-carbaldehyde	ERBB2 EGFR	3.74e-05	3	81	2	CID011228787
Drug	norfenefrine	RNLS PRF1 LOXL4	4.03e-05	19	81	3	CID000004538
Drug	PC9	ERBB2 ERBB4 ERF EGFR	5.83e-05	59	81	4	CID016040245
Drug	Reserpine [50-55-5]; Up 200; 6.6uM; PC3; HT_HG-U133A	ROBO4 SLC2A9 BTNL3 GLB1L LAMA2 SCN3B	6.96e-05	195	81	6	4203_UP
Drug	Solasodine [126-17-0]; Down 200; 9.6uM; MCF7; HT_HG-U133A	ERBB2 LTBP2 ALPK1 MARK2 PPP1R15A CDON	7.36e-05	197	81	6	3924_DN
Drug	PD168393	ERBB4 EGFR	7.47e-05	4	81	2	CID000004708
Drug	tyrphostin AG825	ERBB2 EGFR	7.47e-05	4	81	2	CID000002062
Drug	CHX-A	ERBB2 BTD	7.47e-05	4	81	2	CID000164445
Drug	EGFR/ErbB2 inhibitor	ERBB2 EGFR	7.47e-05	4	81	2	CID009843206
Drug	Rapamycin; Up 200; 0.1uM; HL60; HT_HG-U133A	CTSF CNTN5 AOAH BACE1 LTBP2 CDON	8.00e-05	200	81	6	6167_UP
Drug	AC1NE222	CD93 ERBB2 ERBB4 EGFR	8.53e-05	65	81	4	CID004635324
Drug	BIBX1382BS	ERBB2 ERBB4 EGFR	1.06e-04	26	81	3	CID006918508
Drug	N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine	SLC6A13 RNLS SLC6A16 LOXL4	1.08e-04	69	81	4	CID000003172
Drug	docetaxel	ERBB2 EGFR ACO2 IDH2 ABCC6	1.13e-04	133	81	5	ctd:C067311
Drug	benzylidenemalononitrile	ERBB2 ERBB4 EGFR	1.19e-04	27	81	3	CID000017608
Drug	sodium	SLC6A13 ERBB2 SLC9A5 GALM SLC2A9 SLC6A16 PRF1 PKD1 PRKCG IDH2 CAV3 SCN3B	1.22e-04	944	81	12	CID000000923
Drug	RG 14921	ERBB4 EGFR	1.24e-04	5	81	2	CID000197517
Drug	6-quinolinecarbaldehyde	ERBB4 EGFR	1.24e-04	5	81	2	CID000765653
Drug	TAK-165	ERBB2 EGFR	1.24e-04	5	81	2	CID006444692
Drug	Anilino	ERBB2 EGFR PRKCG	1.48e-04	29	81	3	CID000137550
Drug	1 x OE	ERBB2 ERBB4 EGFR	1.64e-04	30	81	3	CID000449200
Drug	B-31	ERBB2 EGFR	1.86e-04	6	81	2	CID000122475
Drug	Cochliobolic acid	ERBB4 EGFR	1.86e-04	6	81	2	CID006450172
Drug	T 794	RNLS LOXL4	1.86e-04	6	81	2	CID003077680
Drug	NSD 2023	RNLS LOXL4	1.86e-04	6	81	2	CID000019831
Drug	oxalomalic acid	ACO2 IDH2	1.86e-04	6	81	2	CID000439620
Drug	1-benzyl-2-methyl-5-methoxytryptamine	RNLS LOXL4	1.86e-04	6	81	2	CID000009925
Drug	BU99006	RNLS LOXL4	1.86e-04	6	81	2	CID006603748
Drug	5-hydroxyisatin	RNLS LOXL4	1.86e-04	6	81	2	CID010352011
Drug	SnCe6	ERBB4 EGFR	1.86e-04	6	81	2	CID000164259
Drug	1-PCPA	RNLS LOXL4	1.86e-04	6	81	2	CID000194548
Drug	N-cyclopropyl-5,6-dimethoxytryptamine	RNLS LOXL4	1.86e-04	6	81	2	CID000156277
Drug	N-cyclopropyl-6,7-dimethoxytryptamine	RNLS LOXL4	1.86e-04	6	81	2	CID000156278
Drug	N-cyclopropyl-alpha-methylbenzylamine	RNLS LOXL4	1.86e-04	6	81	2	CID000362778
Drug	ZD-6	ERBB2 EGFR	1.86e-04	6	81	2	CID010062753
Drug	diethyl ester	ERBB4 EGFR	1.86e-04	6	81	2	CID000264327
Drug	nicotinamide ribose	IDO1 IGSF9 IDH2 ABCC6	2.11e-04	82	81	4	CID000000940
Drug	lactate	MPV17 ROBO4 GALM BTD ACO2 WBP2NL IDH2 SCN3B	2.35e-04	461	81	8	CID000000612
Drug	harmaline	SLC9A5 RNLS LOXL4	2.40e-04	34	81	3	CID000022381
Drug	dimethylphenethylamine	RNLS LOXL4	2.59e-04	7	81	2	CID000025124
Drug	BU 224	RNLS LOXL4	2.59e-04	7	81	2	CID000002457
Drug	N-(2-aminoethyl)benzamide	RNLS LOXL4	2.59e-04	7	81	2	CID000423156
Drug	cimoxatone	RNLS LOXL4	2.59e-04	7	81	2	CID000052542
Drug	RG 14467	ERBB4 EGFR	2.59e-04	7	81	2	CID000132069
Drug	tetrahydroharmine	RNLS LOXL4	2.59e-04	7	81	2	CID000159809
Drug	4'-amino-MPTP	RNLS LOXL4	2.59e-04	7	81	2	CID000086263
Drug	PKI 166	ERBB2 EGFR	2.59e-04	7	81	2	ctd:C410026
Drug	JB 835	RNLS LOXL4	2.59e-04	7	81	2	CID000152988
Drug	1-benzylcyclopropylamine	RNLS LOXL4	2.59e-04	7	81	2	CID000152923
Drug	secoisolariciresinol diglucoside	ERBB2 EGFR	2.59e-04	7	81	2	ctd:C090142
Drug	MPTP-3-ol	RNLS LOXL4	2.59e-04	7	81	2	CID000100194
Drug	SSFSB	ERBB4 EGFR	2.59e-04	7	81	2	CID003035734
Drug	M 2113	RNLS LOXL4	2.59e-04	7	81	2	CID000072895
Drug	iproclozide	RNLS LOXL4	2.59e-04	7	81	2	CID000019063
Drug	AC1L1JJ0	ERBB2 EGFR	2.59e-04	7	81	2	CID000005061
Drug	brofaromine	RNLS LOXL4	2.59e-04	7	81	2	CID000044570
Drug	deazapurine	ERBB2 EGFR	2.59e-04	7	81	2	CID000261591
Drug	4-methoxytranylcypromine	RNLS LOXL4	2.59e-04	7	81	2	CID003082143
Drug	1-Phenylcyclobutylamine	RNLS LOXL4	2.59e-04	7	81	2	CID000152214
Drug	RS-2232	RNLS LOXL4	2.59e-04	7	81	2	CID000134882
Drug	SR 95191	RNLS LOXL4	2.59e-04	7	81	2	CID000072119
Drug	4-hydroxynonenal	ERBB2 ERBB4 EGFR ACO2 BACE1 ITGA6 PRKCG IDH2	2.71e-04	471	81	8	CID000001693
Drug	alphaNMN	ERF RNLS LOXL4 IDH2	3.01e-04	90	81	4	CID000000939
Drug	sipatrigine	SLC6A13 SLC6A16 SCN3B	3.09e-04	37	81	3	CID000060803
Drug	2-propynylamine	RNLS LOXL4 PRKCG	3.09e-04	37	81	3	CID000239041
Drug	glucose-6-P	CTSF GALM SLC2A9 PRF1 ACO2 IDH2 CREG1	3.28e-04	366	81	7	CID000000208
Drug	AC1O5VTH	RNLS LOXL4	3.45e-04	8	81	2	CID006441710
Drug	AC1Q6B1A	RNLS LOXL4	3.45e-04	8	81	2	CID000088562
Drug	Folfox protocol	ERBB2 EGFR	3.45e-04	8	81	2	ctd:C410216
Drug	pyrazidol	RNLS LOXL4	3.45e-04	8	81	2	CID000068802
Drug	I50 - 9	ERBB4 EGFR	3.45e-04	8	81	2	CID000083651
Drug	citrazinic acid	ACO2 IDH2	3.45e-04	8	81	2	CID000007425
Drug	amezinium	RNLS LOXL4	3.45e-04	8	81	2	CID000071926
Drug	mebanazine	RNLS LOXL4	3.45e-04	8	81	2	CID000006179
Drug	mofegiline	RNLS LOXL4	3.45e-04	8	81	2	CID006437850
Drug	4-fluorotranylcypromine	RNLS LOXL4	3.45e-04	8	81	2	CID003082666
Drug	ranbezolid	RNLS LOXL4	3.45e-04	8	81	2	CID000496993
Drug	2-propyl-pentylamine	RNLS LOXL4	3.45e-04	8	81	2	CID000170419
Drug	2-methylcitric acid	ACO2 IDH2 CDON	3.61e-04	39	81	3	CID000000515
Disease	laryngeal squamous cell carcinoma (is_marker_for)	ERBB2 ERBB4 EGFR CDC73	1.79e-07	19	79	4	DOID:2876 (is_marker_for)
Disease	head and neck squamous cell carcinoma (is_marker_for)	ERBB2 ERBB4 CDC73	1.02e-06	8	79	3	DOID:5520 (is_marker_for)
Disease	Head and Neck Carcinoma	ERBB2 EGFR CDC73	2.19e-06	10	79	3	C3887461
Disease	gallbladder neoplasm	ERBB2 ERBB4 EGFR	3.00e-06	11	79	3	C0016978
Disease	Malignant neoplasm of gallbladder	ERBB2 ERBB4 EGFR	3.00e-06	11	79	3	C0153452
Disease	Neoplasm Recurrence, Local	ERBB2 EGFR IDO1 IDH2	3.64e-06	39	79	4	C0027643
Disease	median neuropathy (biomarker_via_orthology)	ERBB2 ERBB4 EGFR	6.58e-06	14	79	3	DOID:571 (biomarker_via_orthology)
Disease	oral squamous cell carcinoma (is_marker_for)	ERBB2 ERBB4 EGFR CDC73	2.51e-05	63	79	4	DOID:0050866 (is_marker_for)
Disease	Intrahepatic Cholangiocarcinoma	ERBB2 EGFR IDH2	3.59e-05	24	79	3	C0345905
Disease	Extrahepatic Cholangiocarcinoma	ERBB2 EGFR IDH2	3.59e-05	24	79	3	C3805278
Disease	Cholangiocarcinoma	ERBB2 EGFR IDH2	4.59e-05	26	79	3	C0206698
Disease	dilated cardiomyopathy (implicated_via_orthology)	ERBB2 EGFR LTBP2 LMOD2	6.45e-05	80	79	4	DOID:12930 (implicated_via_orthology)
Disease	Cetuximab response	ERBB2 EGFR	7.04e-05	5	79	2	cv:CN077967
Disease	Panitumumab response	ERBB2 EGFR	7.04e-05	5	79	2	cv:CN077999
Disease	Disease Exacerbation	ERBB2 RAP1GAP EGFR CRYBG1 ABCC6	8.30e-05	165	79	5	C0235874
Disease	intestinal cancer (implicated_via_orthology)	ERBB2 ERBB4 EGFR	8.66e-05	32	79	3	DOID:10155 (implicated_via_orthology)
Disease	Head and Neck Neoplasms	ERBB2 EGFR CDC73	9.51e-05	33	79	3	C0018671
Disease	Biliary Tract Neoplasm	ERBB2 IDH2	1.05e-04	6	79	2	C0005426
Disease	GLIOMA SUSCEPTIBILITY 1	ERBB2 IDH2	1.05e-04	6	79	2	C2750850
Disease	Adenocarcinoma of large intestine	ERBB2 ERBB4 EGFR ZNRF3	1.31e-04	96	79	4	C1319315
Disease	Neoplasm of uncertain or unknown behavior of breast	ERBB2 ERBB4 HERC2	1.83e-04	41	79	3	C0496956
Disease	Breast adenocarcinoma	ERBB2 ERBB4 HERC2	1.83e-04	41	79	3	C0858252
Disease	Malignant Head and Neck Neoplasm	ERBB2 EGFR CDC73	2.26e-04	44	79	3	C0278996
Disease	Gout	SLC2A9 ALPK1	2.52e-04	9	79	2	C0018099
Disease	lung adenocarcinoma (is_implicated_in)	ERBB2 ERBB4 EGFR	3.11e-04	49	79	3	DOID:3910 (is_implicated_in)
Disease	3-aminoisobutyrate measurement	SLC6A13 CDC73	4.59e-04	12	79	2	EFO_0010980
Disease	Papilloma	ERBB2 EGFR	4.59e-04	12	79	2	C0030354
Disease	Papillomatosis	ERBB2 EGFR	4.59e-04	12	79	2	C0205875
Disease	Papilloma, Squamous Cell	ERBB2 EGFR	4.59e-04	12	79	2	C0205874
Disease	thyroid gland carcinoma (is_marker_for)	CD93 ROBO4	4.59e-04	12	79	2	DOID:3963 (is_marker_for)
Disease	retinal vasculature measurement	USP2 ERBB4 ACO2 LAMA2 LTBP2 HERC2 MPPED2	4.75e-04	517	79	7	EFO_0010554
Disease	Neoplasm of lung	ERBB2 EGFR	6.31e-04	14	79	2	cv:C0024121
Disease	Lung cancer	ERBB2 EGFR	6.31e-04	14	79	2	cv:C0242379
Disease	LUNG CANCER	ERBB2 EGFR	6.31e-04	14	79	2	211980
Disease	urate measurement	MPV17 USP2 ERBB4 CMIP SLC2A9 SLC25A30 IDH2 MPPED2 TECPR1	6.44e-04	895	79	9	EFO_0004531
Disease	transitional cell carcinoma (is_marker_for)	ERBB2 ERBB4 EGFR	6.53e-04	63	79	3	DOID:2671 (is_marker_for)
Disease	carcinoma (implicated_via_orthology)	ERBB2 ERBB4 EGFR	6.84e-04	64	79	3	DOID:305 (implicated_via_orthology)
Disease	gout, hyperuricemia	SLC2A9 CNTN5	8.29e-04	16	79	2	EFO_0004274, EFO_0009104
Disease	cardiomyopathy (implicated_via_orthology)	ERBB2 ERBB4 EGFR	9.26e-04	71	79	3	DOID:0050700 (implicated_via_orthology)
Disease	muscular dystrophy (is_implicated_in)	LAMA2 CAV3	9.38e-04	17	79	2	DOID:9884 (is_implicated_in)
Disease	Adrenocortical carcinoma	EGFR ZNRF3	1.05e-03	18	79	2	C0206686
Disease	muscular dystrophy (implicated_via_orthology)	LAMA2 CAV3	1.44e-03	21	79	2	DOID:9884 (implicated_via_orthology)
Disease	Carcinoma of lung	ERBB2 EGFR	1.73e-03	23	79	2	C0684249
Disease	stomach carcinoma (is_marker_for)	ERBB2 ERBB4	1.88e-03	24	79	2	DOID:5517 (is_marker_for)
Disease	alcohol use disorder (implicated_via_orthology)	ERBB2 ERBB4 EGFR PRKCG	1.89e-03	195	79	4	DOID:1574 (implicated_via_orthology)
Disease	Malignant neoplasm of breast	ERBB2 ERBB4 RAP1GAP EGFR IDO1 ACO2 LAMA2 HERC2 CNGA2	2.28e-03	1074	79	9	C0006142
Disease	Pancreatic Neoplasm	RAP1GAP EGFR ZNRF3	2.48e-03	100	79	3	C0030297
Disease	Malignant neoplasm of pancreas	RAP1GAP EGFR ZNRF3	2.62e-03	102	79	3	C0346647

Protein segments in the cluster

Peptide	Gene	Start	Entry
YGVGFWKPGSGIIHQ	ACO2	161	Q99798
IAWQGDYGEFVIKDP	ERFL	61	A0A1W2PQ73
IAWQGDYGEFVIKDP	ERF	46	P50548
FGTVYKGIWIPDGEN	ERBB2	731	P04626
SGAFGTVYKGIWVPE	ERBB4	726	Q15303
KGVYVPYTQGKWEGE	BACE1	126	P56817
FYELVSGQWQVTGPG	BTNL3	11	Q6UXE8
FKELEFLGWYTTGGP	COPS6	116	Q7L5N1
VVWGTGKEGQPREYY	CDC73	41	Q6P1J9
LKGFSWVGGGEDTPY	CD93	111	Q9NPY3
GKDGWFQLYSPGGVA	CMIP	521	Q8IY22
ERRPEGGYKAVWFGE	CDHR5	781	Q9HBB8
GGYKAVWFGEDIGTE	CDHR5	786	Q9HBB8
WVTGNGKGLIYLTDP	ALPK1	1181	Q96QP1
ESLGRPQGFEVGYWK	CNTN5	901	O94779
HVFVWGYGILGKGPN	RCC1L	356	Q96I51
NGIWGVDPKDGVPYE	AOAH	231	P28039
EVTVKGFRIYGAPWT	MPPED2	166	Q15777
YGKPVDVWGCGVILF	CASK	196	O14936
GWKGNPQLSDGLVYE	IDO1	236	P14902
EWGQYVDLPKGFAVS	ISOC1	76	Q96CN7
AKYGQGEGPIWLDNV	LOXL4	86	Q96JB6
IQVEGYWIAVGDKEP	MDN1	1036	Q9NU22
DGGFWTVIDGKVYDI	HERC2	1221	O95714
GGKWTFSYIGFPVEL	IL17RB	116	Q9NRM6
QEGYDGGPNLRTKVW	LMOD2	366	Q6P5Q4
GEYQEPGGNVKGVWA	BEX5	26	Q5H9J7
VPEAQNGWLYGKLEG	BAIAP2L2	356	Q6UXY1
KFVPGAWLAGEGVDV	PRF1	36	P14222
FLWDVGSGVGRVEYP	LAMA2	2206	P24043
FGVSELLKAPVDGWY	PRKCG	261	P05129
GAPGTYNWKGIVRVE	ITGA6	206	P23229
IEKGPQYGSLERAWG	PACSIN1	71	Q9BY11
GEEGYPGELKVWVTY	GALM	136	Q96C23
GAFGTVYKGLWIPEG	EGFR	721	P00533
GSGVKEWEVYNFPAG	IDH2	201	P48735
WKPFVYGGLASITAE	SLC25A30	6	Q5SVS4
GDSGQPVDWFVVYKL	DNASE2	21	O00115
KVEGGTWAVYERPNF	CRYGS	41	P22914
PDTYNLVWRAGKDGG	CDON	591	Q4KMG0
VGDTFLYLPGWTKGQ	GLB1L	551	Q6UWU2
VGYGNRSDVPFWAIK	CTSF	436	Q9UBX1
APGGEYFVEGETWNI	CRIM1	681	Q9NZV1
DNFTLVPVWGKEGYL	BTD	401	P43251
AEPVGTYSFDGVWKV	CAV3	46	P56539
GKGYIPVEGAWTFGQ	LTBP2	1466	Q14767
FQGKKYDGPEVDVWS	MARK2	221	Q7KZI7
QTTGGFYPLIGWKIG	GK5	311	Q6ZS86
GKESTWPYLFGVIVV	SLC2A9	226	Q9NRM0
GIWVAYEKPGFTGHQ	CRYBG1	1271	Q9Y4K1
NIWVLDYFGGPKIVT	CREG1	196	O75629
ATGVFLKSWVYQPGE	PPP1R15A	381	O75807
GVLYTWDFGDGSPVL	PKD1	1156	P98161
GSSAKWVGPFYIGDR	NYNRIN	1841	Q9P2P1
GNPKTVGFYLGTWRD	TRMT2B	166	Q96GJ1
KIIAPWIGGVGYSSF	SLC6A16	176	Q9GZN6
VVGYWPKATGTNREG	TMEM200C	71	A6NKL6
YQLVDGGRFTLWGPE	TADA2B	51	Q86TJ2
AGWPAGKDSIQYGRV	ABCC6	916	O95255
HENGPFVLYGIVSWG	OVCH1	771	Q7RTY7
RILGGSQVEKGSYPW	OVCH2	51	Q7RTZ1
ILLPQFGGYWIEGTN	RAP1GAP	46	P47736
ELPWKSGQGDLAVYV	SLC9A5	761	Q14940
FVGPVVGGWYKVLDR	MPV17	61	P39210
VGGWYKVLDRFIPGT	MPV17	66	P39210
DKNWFYKEDVAGGPG	ODF3L1	186	Q8IXM7
YFEFKIQSTGIWGIG	SPRYD7	66	Q5W111
GGLHWGQDYEFKVRP	ROBO4	311	Q8WZ75
ISKSIGFGVDTWVYP	CNGA2	296	Q16280
WKPFVYGGLASIVAE	SLC25A14	41	O95258
PKDFATLYQGWGVSG	ZNF516	1066	Q92618
LGLFYEAGTKIDVPW	RNLS	196	Q5VYX0
EAGTKIDVPWAGQYI	RNLS	201	Q5VYX0
ENFGGEPTEKGGWTY	TECPR1	126	Q7Z6L1
FDEYWTLIGGITGPI	S100A16	76	Q96FQ6
AGEIIGLGNVWRFPY	SLC6A13	46	Q9NSD5
AAPYGGWEGQATFKL	WBP2NL	101	Q6ICG8
ATTVVEWFYRPEGGK	SCN3B	56	Q9NY72
KRILAPYVGGWGETN	PKHD1L1	2686	Q86WI1
PYVGGWGETNGAVIK	PKHD1L1	2691	Q86WI1
KGANVSWEPGFDGGY	IGSF9	521	Q9P2J2
YEYGWVGVVKLEQPE	ZNRF3	116	Q9ULT6
VVFRSPGGVHWGYEE	ZSCAN29	401	Q8IWY8
IGRYTLWETGKGQAP	USP2	231	O75604
TWNFLQSIYGGGPEV	USP33	901	Q8TEY7
SIVVKGYNIWTGGPD	TLE6	426	Q9H808
FWQVDHIKPVYGGGG	ZRANB3	1016	Q5FWF4